Ringer lactate similar to standard salt solution

Article

Ringer lactate has a similar effect to a fortified balanced salt solution on corneal endothelial cell loss after phacoemulsification.

Ringer lactate similar to standard salt solution

Ringer lactate has a similar effect to a fortified balanced salt solution on corneal endothelial cell loss after phacoemulsification.

A team led by Dr Barun K. Nayak, Hinduja Hospital, Veer Sawarkar Marg, Mahim, Mumbai, India, conducted a prospective randomized controlled double-blinded clinical study on 75 eyes of 75 patients with senile cataract up to nuclear grade III. All patients were randomized to receive a fortified balanced salt solution (Group A) or Ringer lactate (Group B) as an intraocular irrigating solution.

Corneal endothelial cell density was the primary outcome and pachymetry was recorded preoperatively and one week and one and six months after treatment.

The results revealed no significant difference in postoperative percentage of endothelial cell loss between the two groups at one week, one month and 6 month follow-ups.

Postoperative percentage change in pachymetry was not significant between the two groups at the one week or one month follow-ups but there was a significant difference at the six-month follow-up.

The abstract was published in the Journal of Cataract and Refractive Surgery .

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.